Janus Henderson Group’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-233,950
Closed -$3.1M 2543
2024
Q4
$3.1M Sell
233,950
-22,497
-9% -$298K ﹤0.01% 1098
2024
Q3
$3.65M Sell
256,447
-52,871
-17% -$752K ﹤0.01% 1013
2024
Q2
$4M Buy
309,318
+111,894
+57% +$1.45M ﹤0.01% 938
2024
Q1
$2.74M Sell
197,424
-46,828
-19% -$650K ﹤0.01% 1139
2023
Q4
$3.49M Sell
244,252
-143,766
-37% -$2.05M ﹤0.01% 973
2023
Q3
$6M Sell
388,018
-8,753
-2% -$135K ﹤0.01% 775
2023
Q2
$6.23M Sell
396,771
-15,047
-4% -$236K ﹤0.01% 801
2023
Q1
$6.79M Sell
411,818
-15,842
-4% -$261K ﹤0.01% 794
2022
Q4
$6.67M Sell
427,660
-456,592
-52% -$7.12M ﹤0.01% 804
2022
Q3
$11.5M Buy
884,252
+427,177
+93% +$5.54M ﹤0.01% 795
2022
Q2
$6.42M Sell
457,075
-10,685
-2% -$150K ﹤0.01% 792
2022
Q1
$6.7M Buy
467,760
+57,950
+14% +$830K ﹤0.01% 956
2021
Q4
$5.59M Sell
409,810
-55,610
-12% -$758K ﹤0.01% 1043
2021
Q3
$7.62M Sell
465,420
-111,214
-19% -$1.82M ﹤0.01% 957
2021
Q2
$9.71M Sell
576,634
-74,960
-12% -$1.26M ﹤0.01% 941
2021
Q1
$11.9M Buy
651,594
+69,243
+12% +$1.26M 0.01% 868
2020
Q4
$10.6M Sell
582,351
-118,798
-17% -$2.16M ﹤0.01% 860
2020
Q3
$12.5M Sell
701,149
-54,588
-7% -$974K 0.01% 793
2020
Q2
$13.6M Buy
755,737
+20,138
+3% +$361K 0.01% 771
2020
Q1
$11.2M Sell
735,599
-475,057
-39% -$7.21M 0.01% 800
2019
Q4
$23.9M Sell
1,210,656
-215,825
-15% -$4.26M 0.01% 781
2019
Q3
$24.5M Sell
1,426,481
-54,006
-4% -$929K 0.01% 780
2019
Q2
$26.2M Buy
1,480,487
+17,087
+1% +$302K 0.01% 735
2019
Q1
$29.8M Buy
1,463,400
+781,068
+114% +$15.9M 0.02% 697
2018
Q4
$11.5M Buy
+682,332
New +$11.5M 0.01% 875